| 000 | 01642nam a2200217Ia 4500 | ||
|---|---|---|---|
| 003 | NULRC | ||
| 005 | 20250520094922.0 | ||
| 008 | 250520s9999 xx 000 0 und d | ||
| 020 | _a8123911580 | ||
| 040 | _cNULRC | ||
| 050 | _aRS 192 .B56 2004 | ||
| 245 | 0 |
_aBioavailability and bioequivalence in pharmaceutical technology / _cedited by Tapan Kumar Pal and M. Ganesan |
|
| 260 |
_aNew Delhi, India : _bCBS Publishers & Distributors, _cc2004 |
||
| 300 |
_aviii, 159 pages : _billustrations ; _c25 cm. |
||
| 504 | _aIncludes bibliographical references. | ||
| 505 | _aEthical issues involved in Bioequivalence study -- Understanding bioavailability -- Bioavailability studies in man: pharmacokinetic considerations -- Method of sample preparation and HPLC analysis of some common drugs from biological fluids -- Application of HPLC for analysis of biological samples and drugs -- Microdialysis and its application in bioavailability studies -- Ocular kinetics and drug delivery systems of ophthalmic medicines- a review -- Bioequivalence study and data interpretation -- Introduction to bio-analytical method development and validation for bioavailability and bio-equivalence studies -- High performance liquid chromatography, an upgraded technology for the monitoring of therapeutic drugs -- Systematic clinical and toxicological analysis using solid phase extraction -- Bioequivalence of Gatifloxacin by HPLC method- a case study | ||
| 520 | _aProceedings of the Seminar-cum-Workshop on Bioavailability and Bioequivalence. | ||
| 650 | _aDRUGS BIOAVAILABILITY | ||
| 700 |
_aPal, Tapan Kumar;Ganesan, M. _eeditor;editor |
||
| 942 |
_2lcc _cBK |
||
| 999 |
_c6245 _d6245 |
||